The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Firms / T•••• R••• V•••••••• L•••

T•••• R••• V•••••••• L•••

Institutional venture firmBoston, MAt•••••••••.comSEC venture capital fund adviserfundraising evidence

T•••• R••• V••••••• is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…

venture manager, reported GAV $2,417M across 7 vehicles

Importance
39
elevated
Active deployment
39
elevated
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
16
moderate
Identity and regulatory footprint
Headquarters
Boston, MAadviserinfo.sec.gov
Office address
201 BROOKLINE AVE, SUITE 1401, Boston, MA, 02215adviserinfo.sec.gov
Business phone
617-585-2000adviserinfo.sec.gov
Website
t•••••••••.com
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 19, 2026
Private funds reported
5 (5 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$1.9Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
T•••• R••• V••••••• H•••••••• L••• (Member), E; T•••• R••• V••••••• M••••••••• L•• (General Partner), F
business phone
617-585-2000adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
Sectors
biotech
Stages
not stated or not yet read
Geography
boston
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate 100%follow-on rate n/anew logos, 12 months 1
Funds and vehicles
7 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
T•••• R••• V••••••• V•• L•••Fund2022 form d first saleActive deployment$1.1B
Mar 26, 2024
66$1.1B
of $1.1B
Jun 10, 2022
T•••• R••• V••••••• V• L•••Fund2019 form d first saleMature$726M
Mar 26, 2024
68$750M
of $750M
Jun 7, 2019
T•••• R••• V••••••• I•• L•••Fund2016 form d first saleHarvest$510M
Mar 26, 2024
58$600M
of $600M
Nov 2, 2016
T•••• R••• V••••••• I••• L•••Fund2013 form d first saleHarvest$33.7M
Mar 26, 2024
60$500M
of $500M
Mar 25, 2013
T•••• R••• V•••••••• L•••FundunknownUnknown$27.8M
Mar 26, 2024
27unknownunknown
T•••• R••• V••••••• I•• L•••FundunknownUnknown$8.7M
Mar 26, 2024
48$0
of $400M
Apr 9, 2010
T•••• R••• V••••••• V••• L•••FundunknownFundraisingunknownunknown$0
of $750M
Jun 3, 2026
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
13 current, 3 departed
A•••• C•••••••
Manager/Member · since Jan 1, 2022
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
A•••• C•••••••
Executive Officer · since Sep 1, 2016
Partner
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
J••• K• T•••
Manager/Member · since Jan 1, 2022
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
J•••••• K• T•••
Executive Officer · since May 1, 2019
Partner
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
K•••• M•••••• G•••••
Manager/Member · since Jan 1, 2022
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
R••• M• H••••
Manager/Member · since Jan 1, 2022
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
R••• M• H••••
Executive Officer · since May 1, 2019
Partner
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
R••••• I•• T•••••
Manager/Member · since Dec 1, 2014
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
R••••• I•• T•••••
Executive Officer · since Dec 1, 2014
Partner
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
A••••• C••••••
Chief Financial Officer · since Jan 1, 2022
Platform and operations
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
A••••• C••••••
Chief Financial Officer · since Jan 1, 2022
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Platform and operations
FactVenture organization websites (about, team, portfolio, thesis, news pages)
K•••• M•••••• G•••••
Chief Operating Officer · since Dec 1, 2018
Platform and operations
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
3 departed (kept with end dates)
Investments on record
1 edges, 1 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
A•••••••portfolio listingleadunknownunknownunknownSep 17, 2026Fact Portfolio company websites (about, investors, press pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
1 relationships from shared deals, counted for the whole firm
Mission Biocapital 1 shared · one time · we led 1
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
15 dated events
  1. Mar 29, 2023
    T•••• R••• V••••••• V•• L••• first reported on Form ADV by T•••• R••• V•••••••• L••• (Venture Capital Fund), GAV $1,112,827,403
    Fund first reported on Form ADVFundsFactT•••• R••• V••••••• V•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Mar 31, 2022
    M••• J•• L•••• (Manager/Member) no longer on Schedule A of T•••• R••• V•••••••• L•••
    Person leftPeopleInferenceM••• J•• L••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Mar 31, 2022
    K•••• P••• S•••• (Manager/Member) no longer on Schedule A of T•••• R••• V•••••••• L•••
    Person leftPeopleInferenceK•••• P••• S••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Jan 1, 2022
    A••••• C•••••• joined Schedule A of T•••• R••• V•••••••• L••• as Chief Financial Officer
    Person joinedPeopleFactA••••• C••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Mar 27, 2020
    T•••• R••• V••••••• V• L••• first reported on Form ADV by T•••• R••• V•••••••• L••• (Venture Capital Fund), GAV $759,041,570
    Fund first reported on Form ADVFundsFactT•••• R••• V••••••• V• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. May 1, 2019
    R••• M• H•••• joined Schedule A of T•••• R••• V•••••••• L••• as Executive Officer
    Person joinedPeopleFactR••• M• H••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. May 1, 2019
    J••• K• T••• joined Schedule A of T•••• R••• V•••••••• L••• as Executive Officer
    Person joinedPeopleFactJ••• K• T•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  8. Mar 19, 2019
    A••••• B••••• (Effective Officer) no longer on Schedule A of T•••• R••• V•••••••• L•••
    Person leftPeopleInferenceA••••• B•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  9. Mar 23, 2017
    T•••• R••• V••••••• I•• L••• first reported on Form ADV by T•••• R••• V•••••••• L••• (Venture Capital Fund), GAV $616,075,000
    Fund first reported on Form ADVFundsFactT•••• R••• V••••••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  10. Sep 1, 2016
    A•••• C••••••• joined Schedule A of T•••• R••• V•••••••• L••• as Effective Officer
    Person joinedPeopleFactA•••• C•••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  11. Sep 1, 2016
    A••••• B••••• joined Schedule A of T•••• R••• V•••••••• L••• as Effective Officer
    Person joinedPeopleFactA••••• B•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  12. Mar 27, 2013
    T•••• R••• V••••••• I••• L••• first reported on Form ADV by T•••• R••• V•••••••• L••• (Venture Capital Fund), GAV $515,630,000
    Fund first reported on Form ADVFundsFactT•••• R••• V••••••• I••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  13. Mar 28, 2012
    T•••• R••• V•••••••• L••• first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  14. Mar 28, 2012
    T•••• R••• V••••••• I•• L••• first reported on Form ADV by T•••• R••• V•••••••• L••• (Venture Capital Fund), GAV $408,734,420
    Fund first reported on Form ADVFundsFactT•••• R••• V••••••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  15. Mar 28, 2012
    T•••• R••• V•••••••• L••• first reported on Form ADV by T•••• R••• V•••••••• L••• (Venture Capital Fund), GAV $344,210,698
    Fund first reported on Form ADVFundsFactT•••• R••• V•••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $2,417M across 7 vehicles
Evidence
55 observations from 4 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-28Mar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-19Mar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-26Mar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2012-03-28Mar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone617-585-2000Mar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone617-585-2000Mar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionT•••• R••• V••••••• is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…
“meta description”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionT•••• R••• V••••••• is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…
“meta description”
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersBoston, MAMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersBoston, MAMar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address201 BROOKLINE AVE, SUITE 1401, Boston, MA, 02215Mar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address201 BROOKLINE AVE, SUITE 1401, Boston, MA, 02215Mar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyMar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://t•••••••••.com/
“0 entries read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://t•••••••••.com/
“0 entries read”
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported5Mar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported6Mar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$1.9BMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$2.4BMar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Schedule a diffsadiff-1Mar 19, 2026FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
Stated geographyboston
“geography words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyboston
“geography words on the home page”
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
“sector words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
“sector words on the home page”
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://t•••••••••.com/
“1 name/title pairs read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://t•••••••••.com/
“1 name/title pairs read”
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported5Mar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported6Mar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://w••.t•••••••••.comMar 19, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTP://w••.t•••••••••.comMar 26, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleT••••rockventures | Home Page
“title tag”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleT••••rockventures | Home Page
“title tag”
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)